Depomed, Inc. (NASDAQ:DEPO) announced that it will be presenting at two upcoming investor, Bank of America Merrill Lynch Healthcare Conference in Las Vegas Nevada on Thursday May 15 at 11:00 am Eastern Time (8:00 am Pacific Time). UBS Global Healthcare Conference in New York City on Monday May 19 at 9:00 am Eastern Time (6:00 am Pacific Time). Depomed Inc. (NASDAQ:DEPO) stock opened today at $11.24 and is currently trading at $11.86. The stock showed a negative weekly performance of -24.18%.
Insys Therapeutics (NASDAQ:INSY) will be issuing its Q114 quarterly earnings data on Tuesday, May 13th. Analysts expect the company to announce earnings of $0.28 per share and revenue of $45.63 million for the quarter. Insys Therapeutics Inc. (NASDAQ:INSY) stock opened at $29.79, in current trading session and currently is at $27.75, by losing -16.28%. The 52 week range of $6.20 – $57.91. Company’s market capitalization is 948.88 million.
Durata Therapeutics (NASDAQ:DRTX) announced its earnings results on Thursday. The company reported ($0.62) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.64) by $0.02, Analyst Ratings News reports. Durata Therapeutics Inc. (NASDAQ:DRTX) stock is currently trading at $14.85. The EPS of the stock is -2.64. Company’s market capitalization is 395.61 million.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has named a new program to its pipeline: ALN-HBV for the treatment of hepatitis B virus (HBV) infection. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stock opened the session at $57.30, and now is at $56.12. The 52 week range of the Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stock remained $24.75 – $112.57 and the day range was $54.46 – $57.49.